Accelerated Cure Project receives additional funding for the multicenter longitudinal OPT-UP clinical study in MS
— Study to enable optimal treatment strategies for MS is expected to start Q1 2016 — Waltham, MA, October 8, 2015 – Accelerated Cure Project for Multiple Sclerosis (ACP) announced today that Genentech, Inc., a member of the Roche Group, has become a Founding Sponsor for the Optimizing Treatment – Understanding Progression (OPT-UP) clinical study in … Read more